Mechanism and structural diversity of exoribonuclease-resistant RNA structures in flaviviral RNAs by MacFadden, A. et al.
ARTICLE
Mechanism and structural diversity of
exoribonuclease-resistant RNA structures in
flaviviral RNAs
Andrea MacFadden1, Zoe O’Donoghue1, Patricia A.G.C. Silva2, Erich G. Chapman1,7, René C. Olsthoorn3,
Mark G. Sterken4,5, Gorben P. Pijlman4, Peter J. Bredenbeek2 & Jeffrey S. Kieft 1,6
Flaviviruses such as Yellow fever, Dengue, West Nile, and Zika generate disease-linked viral
noncoding RNAs called subgenomic flavivirus RNAs. Subgenomic flavivirus RNAs result when
the 5′–3′ progression of cellular exoribonuclease Xrn1 is blocked by RNA elements called
Xrn1-resistant RNAs located within the viral genome’s 3′-untranslated region that operate
without protein co-factors. Here, we show that Xrn1-resistant RNAs can halt diverse
exoribonucleases, revealing a mechanism in which they act as general mechanical blocks that
‘brace’ against an enzyme’s surface, presenting an unfolding problem that confounds further
enzyme progression. Further, we directly demonstrate that Xrn1-resistant RNAs exist in a
diverse set of flaviviruses, including some specific to insects or with no known arthropod
vector. These Xrn1-resistant RNAs comprise two secondary structural classes that mirror
previously reported phylogenic analysis. Our discoveries have implications for the evolution
of exoribonuclease resistance, the use of Xrn1-resistant RNAs in synthetic biology, and the
development of new therapies.
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F laviviruses are single-stranded, (+)-sense RNA viruses with10–11 kb-long genomes1. Infection by mosquito-borneflaviviruses (MBFVs) results in amplification of the geno-
mic RNA (gRNA) and also production of noncoding subgenomic
flaviviral RNAs (sfRNAs)2–8. sfRNAs accumulate to high levels,
interacting with many cellular proteins to influence processes
such as RNA interference, proper cellular RNA decay, the
interferon response, and the process of transmission between
mosquito vector and vertebrate host9–19. sfRNAs have been
implicated in cytopathicity in cell culture and in pathogenicity in
fetal mice6,20, thus they are directly related to disease symptoms
and are potential therapeutic targets.
MBFV sfRNAs are formed by partial degradation of the viral
genomic RNA by cellular 5′–3′ exoribonuclease Xrn1, an
important enzyme in normal RNA decay pathways that degrades
5′ monophosphorylated RNAs (Fig. 1a)21. MBFV genomes
contain discrete RNA structures in their 3′-untranslated region
(UTR) that block the progression of Xrn1. These RNA elements
are sufficient to block Xrn1 without the use of accessory proteins,
thus they have been assigned the name ‘Xrn1-resistant RNAs’
(xrRNAs)6,13,22–27. xrRNAs halt the enzyme at a defined location
such that the viral RNA located downstream of the xrRNAs is
protected from degradation. These protected RNAs are sfRNAs,
and in some but not all cases multiple xrRNA structures give rise
to multiple sfRNA species (Fig. 1a)6,11,17,22–29.
Xrn1 can unwind and degrade highly structured RNAs such as
picornaviral IRES elements6 and ribosomal RNA, thus the ability
of discrete RNA structures in MBFVs to block the progression of
Xrn1 is surprising, and the mechanism was poorly understood.
Structures of xrRNAs from Murray Valley encephalitis virus
and Zika virus solved by x-ray crystallography revealed that a
three-way junction and multiple pseudoknot interactions create
an unusual and complex fold that requires a set of nucleotides
conserved across the MBFVs23,27. In the fold, the 5′-end of the
RNA passes through a ring-like structure (Fig. 1b), and modeling
suggested that resistance occurs when this ring-like structure
contacts the surface of Xrn1. However, the mechanism of how
this leads to Xrn1 resistance remained speculative. It has been
proposed that Xrn1’s helicase function involves two alpha helices
that assist in unwinding double-stranded RNA, producing 5–6
nucleotides of single-stranded RNA that span the distance from
the enzyme’s surface to its active site where the RNA is
cleaved30,31. Based on this, various mechanistic ideas could be
proposed: i) the conserved xrRNA structure and sequence could
make specific contacts to Xrn1’s surface to prevent helicase
activity or block enzyme conformational changes, ii) it could
somehow alter the specific catalytic mechanism of Xrn1’s active
site, iii) it could use nonspecific physical interactions with the
enzyme, iv) it could present a general mechanical unfolding
problem, or it could use some combination of these strategies.
In addition, although the formation of sfRNA in the MBFVs
and tick-borne flaviviruses (TBFVs) is well-established6,28,32,
direct evidence is lacking for whether other non-arthropod-borne
flaviviruses also form sfRNAs. These flaviviruses include mem-
bers of the no known arthropod vector flaviviruses (NKVFVs)
that infect small mammals and bats, and the insect-specific
flaviviruses (ISFVs) that have no identified vertebrate host. While
the sequences of MBFV xrRNAs contain a number of absolutely
conserved nucleotides within a shared three-dimensional fold6,25,
the non-MBFV putative xrRNAs do not have the same sequences
as those found in MBFVs19,28,29. If these ISFVs and NKVFVs do
form sfRNAs, this raises questions of whether they arise from
folded RNA structures that function without protein co-factors,
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Fig. 1 Formation of sfRNAs by Xrn1 resistance. a Xrn1 degrades the viral genomic RNA in a 5′–3′ direction, but halts at xrRNA structures. The resultant
noncoding viral sfRNA is formed, which affects several pathways. b Three-dimensional structure of the upstream xrRNA from Zika virus shown in cartoon
form, in rainbow. The 5′-end is blue and 3′-end is red. The fold forms a unique ring-like structure (yellow box) through which the 5′-end of the RNA passes.
The location of this xrRNA in a generic MBFV 3′-UTR is shown above the structure
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Here, we describe studies to address fundamental questions of
the mechanism underlying Xrn1 resistance by MBFV xrRNAs
and the existence and structure of xrRNAs from other flavi-
viruses. Using a biochemical approach, we discovered that
xrRNAs can halt exoribonucleases unrelated to Xrn1 and that the
nature of the interface between the RNA and the enzyme affects
where the enzyme halts. This reveals that xrRNAs operate as
general mechanical blocks to diverse molecular machines, with
implications for the use of these RNAs in diverse contexts. Fur-
thermore, we directly demonstrate that Xrn1 resistance can be
achieved by sequences within the 3′-UTR of flavivirus RNAs
outside of the MBFVs, but that in some groups the xrRNAs use a
secondary structural strategy that differs from that of the MBFVs.
By extension, structured exoribonuclease-resistant RNAs may be
widespread, possibly conferring novel pathways for RNA
maturation or regulation of mRNA decay.
Results
A flaviviral xrRNA can block diverse exoribonucleases. A key
question to understand the mechanism of xrRNA function is the
specificity for Xrn1; if xrRNAs can block other unrelated enzymes
it eliminates the need for specific RNA–protein interactions, for
conformational changes unique to Xrn1, or for other Xrn1-
specific features. We therefore tested the ability of a MBFV
xrRNA to block 5′–3′ exoribonucleases other than Xrn1 using our
previously characterized assay (Supplementary Fig. 1), reasoning
that if these enzymes degrade through the structure, then specific
Xrn1-xrRNA interactions are likely necessary for the mechanism.
We chose the second of two tandem xrRNAs (xrRNA2) from the
Kunjin strain of West Nile Virus (WNVKUN) as a representative
xrRNA and challenged it with pure bacterial RNase J1, a 5′–3′
exoribonuclease unrelated to Xrn1 (Fig. 2a)33,34. The xrRNA
effectively blocked the progression of the enzyme (Fig. 2a, lane 3).
We then tested an xrRNA mutated (C10680G) to alter its three-
dimensional fold and ablate Xrn1 resistance22,23,27. RNase J1
degraded this mutant RNA (Fig. 2a, lane 7). We then challenged
the xrRNA with yeast exoribonuclease Dxo1, an enzyme that
removes aberrant 5′ caps and also degrades RNA in a 5′–3′
direction35. Similar to RNase J1, the wild-type xrRNA resisted
degradation by Dxo1 but the C10680G mutant did not (Fig. 2a,
lanes 4, 8). These results indicate that the xrRNA can block
diverse exoribonucleases in a manner that depends on its specific
fold but does not depend on an enzyme-specific mechanism of
processive RNA degradation or specific enzyme-xrRNA
interactions.
Different exoribonucleases halt at different locations. To
understand similarities or differences in the interactions driving
an xrRNA’s ability to block diverse 5′–3′ exoribonucleases, we
mapped each aforementioned enzyme’s xrRNA-induced halt site
using a primer extension method (Fig. 2b, c)22. Interestingly,
RNase J1 halts a single nucleotide upstream (5′) of Xrn1’s halt
site. Because these exoribonucleases have narrow entrance
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Fig. 2 Testing the mechanism of exoribonuclease resistance. a Exoribonuclease resistance assay of wild-type and mutant WNV xrRNA2, using different
exoribonucleases. b Reverse transcription mapping of the halt sites of the exoribonucleases. c Secondary structure of the test xrRNA with the location of
the point mutation and the halt sites for all of the exoribonucleases indicated. Gels are representative of greater than three independent experiments
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to enter, the difference in halt sites likely correlates with the
distance between the active site and the surface of each
enzyme33,35. In contrast to RNase J1, the halt site of Dxo1 was
somewhat poorly defined, with the enzyme appearing to ‘stutter’
as it interacts with the xrRNA (Fig. 2b, c). These results have
mechanistic implications. They further support the idea that the
xrRNA is a general mechanical block in which the ring structure
braces against the enzyme’s surface around the active site
entrance, and the enzyme halt site reflects the distance between
the surface and the active site. However, although the xrRNA-
enzyme interactions are not specific to a certain enzyme, the
geometry or other characteristics of the enzyme’s surface affect
the precision of the halting event.
xrRNAs in MBFVs and ISFVs use a similar structural strategy.
RNA structure-dependent Xrn1 resistance in vitro has been
observed by many MBFV xrRNAs and they have been char-
acterized biochemically, functionally, and biophysically22,25; in
contrast, the characteristics of putative xrRNAs from other fla-
viviruses are more mysterious. In the MBFVs, the xrRNAs exhibit
a high degree of sequence conservation with one another and they
almost certainly all form a similar three-dimensional fold6,25, but
the sequences of the 3′-UTRs of flaviviruses outside of the MBFVs
do not contain the same sequences that are absolutely conserved
in the MBFV xrRNAs.
We first explored sfRNA production by a representative ISFV,
cell-fusing agent virus (CFAV), by infecting C6/36 cells. Northern
blot analysis with a probe to the 3′-end of the viral RNA revealed
a robust band consistent with the production of sfRNA, and
reverse transcription showed the location in the 3′-UTR (Fig. 3a).
To determine whether sfRNA production is owing to Xrn1
resistance, we challenged in vitro- transcribed RNA of the CFAV
3′-UTR with purified Xrn1. The 3′-UTR RNA was processed to a
single shorter degradation intermediate, indicating the presence
of at least one authentic xrRNA (Fig. 3b). We mapped the enzyme
halt site on the in vitro-processed RNA, revealing the location of
the most upstream Xrn1-resistant element (Fig. 3c). As the RNA
sequence downstream of the halt site does not match that of the
characterized MBFV xrRNAs, we used selective 2′-hydroxyl
acylation analyzed by primer extension (SHAPE) combined with
thermodynamic predictions to generate an experimentally
supported secondary structural model (Supplementary Fig. 2).
We also found evidence for a second similar structural element
further downstream in the 3′-UTR that likely comprises a second
CFAV xrRNA.
Examination of these secondary structures show that several
tertiary structure interactions critical for maintaining the three-
dimensional structure of the MBFV xrRNAs can also form in the
CFAV xrRNAs (Fig. 3d). Specifically, there is potential for base
pairing between two nucleotides at the 5′-end and two nucleotides
in the three-way junction, for the formation of a long-range
pseudoknot between the L3 loop and the S4 region downstream,
and for a non-canonical base pair that helps define the ring
around the 5′-end. This suggests that these CFAV xrRNAs fold
similarly to the MBFV xrRNAs.
Despite the aforementioned similarities, several critical tertiary
interactions present in the MBFVs are missing or altered in the
CFAV xrRNAs, including a U•A-U base triple interaction
absolutely conserved in the MBFVs. Interestingly, in the CFAV
xrRNAs, the U base and A-U base pair that form the triple have
been replaced by a C base and G-C base pair (Fig. 3d, e). We
predict that this triple substitution allows formation of a C+•G-C
base triple, which is isosteric with the U•A-U and thus can
structurally replace it. To test this, we generated mutant versions
of the xrRNA and tested them for Xrn1 resistance in vitro
(Fig. 3f). Substitution of the G-C with an A-U in the upstream
xrRNA (disrupting the putative base triple) eliminated robust
Xrn1 resistance and allowed the enzyme to progress to the
downstream xrRNA (Fig. 3f). When the C was replaced with a U
(fully replacing the putative C+•G-C with a U•A-U), resistance
was recovered; this provides strong evidence for the existence of a
base triple (Fig. 3f). In addition, in the MBFVs there is an
absolutely conserved C in the three-way junction that makes
hydrogen bonds with the backbone and with base functional
groups in the P1 stem22. In both CFAV xrRNAs, this C is
replaced by a U, but we predict this mutation is tolerated within
the overall fold (Fig. 3e). We mutated this U to either a C or an A;
both were able to block Xrn1 in vitro (Fig. 3f). Interestingly, the
P1 stem is considerably shorter in the CFAV xrRNAs than in the
MBFVs. This may be tolerated by adjustments to other parts of
the RNA fold; understanding how this is achieved will require
three-dimensional structural information. By aligning the
sequences of predicted xrRNAs from several members of the
ISFVs, conserved tertiary interaction patterns emerge (Fig. 3g).
These results suggest that these ISFV xrRNAs all adopt a three-
dimensional fold similar to MBFV xrRNAs and use the same
topological strategy to block Xrn1.
More divergent flaviviruses use different xrRNA structures. In
addition to the ISFVs, other flaviviruses include the TBFVs and
NKVFVs. sfRNA formation has been reported in the TBFVs6,32,
and the structures that are responsible for sfRNA formation have
highly conserved sequences that do not match those of the
MBFVs32. The NKVFVs do not comprise a single phylogenetic
group. Examination of at least one member, Yokose Virus
(YOKV), reveals a sequence that matches the xrRNA patterns of
the MBFVs25, but many other members do not have this
sequence pattern. To examine sfRNA formation in these diver-
gent NKVFVs, we infected BHK-21J cells with Modoc virus
(MODV), Montana myotis leukoencephalitis virus (MMLV),
Apoi virus (ApoiV), and Rio Bravo Virus (RBV); these represent
various groups of NKVFVs. Northern blot analysis with probes
to the 3′-ends of the viruses revealed the presence of sfRNAs
in all (Fig. 4a). Reverse transcription mapping showed that the
5′-end of these sfRNAs was within the 3′-UTR of the viral RNA
(Fig. 4b).
To determine whether these sfRNAs result from Xrn1
resistance and operate without protein co-factors, we chose
representative members of the NKVFV and TBFV virus groups
and challenged their 3′-UTR RNAs with Xrn1 (Fig. 4c, d).
Specifically, we used in vitro-transcribed RNA comprising the full
3′-UTRs of MODV, MMLV, and TBEV. These 3′-UTRs were
processed to a shorter degradation intermediate by Xrn1,
indicating the presence of at least one authentic xrRNA.
Interestingly, the 3′-UTR of TBEV gave rise to multiple
degradation intermediates, unusual as generally we observe only
a single degradation intermediate in vitro, corresponding to the
most upstream xrRNA even when multiple xrRNAs exist in the
3′-UTR. We mapped the location of all Xrn1 halt sites; as with the
MBFV xrRNAs, the halt sites are precise to within one or two
nucleotides and their location matches those mapped on RNAs
from infected cells (Fig. 4b, e, f).
RNA sequences downstream of the halt sites in the TBFVs and
NKVFVs do not contain the conserved sequences observed in
MBFV xrRNAs, thus they may use a different structural strategy
to halt Xrn1. Indeed, the secondary structures of these RNAs have
been predicted28,29,32, but they have not been experimentally
examined. We therefore used SHAPE combined with thermo-
dynamic and phylogenetic analysis to generate secondary
structure models of the MODV, MMLV, and TBEV xrRNAs
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(Fig. 5a–c). In all three RNAs, the mapped halt sites are followed
by a similar secondary structure (two copies of this secondary
structure are seen in TBEV); the similarity of these secondary
structures across viral species increases the confidence that the
models are correct. The secondary structures of these divergent
xrRNAs contain a three-way junction, but one that differs from
those found in the MBFVs and ISFVs. Whereas the three-
dimensional structures of MBFVs revealed that these three-way
junctions are of the “C” family, assignment of the family of these
TBFV and NKVFV xrRNAs is ambiguous and thus the stacking
arrangements of the emerging helices are difficult to predict36,37.
In addition, although in the MBFVs the halt site is 5–6
nucleotides before the base of the P1 stem in a single-stranded
region, in the MODV, MMLV, and both TBEV xrRNAs, the halt
site corresponds to a bulge in a stem, and there is no analogous
distance between the halt site and the junction (Fig. 5a–c).
Overall, these xrRNAs appear to comprise a different secondary
structural class compared to the MBFV xrRNAs (Fig. 6a).
An interesting putative interaction in the MODV, MMLV, and
both TBEV xrRNAs is long-range base pairing between an apical
loop and a sequence ~30–40 nucleotides downstream (Fig. 5a–c,
green sequences and arrows)28,32. The MBFV xrRNAs also
contain a long-range base pairing interaction that forms a
functionally critical pseudoknot (green, Fig. 3d)22,24,26, but in the
MBFV xrRNAs the length of intervening sequences is shorter and
mostly involved in secondary and tertiary structure6,25. Hence, it
is not clear if the long-range pairing in the MODV, MMLV, and
both TBEV xrRNAs is analogous to that observed in the MBFV
xrRNAs. In the MODV xrRNA, the putative base pairing is
between a 5′-UGAC-3′ sequence in the apical loop and a
5′-GUCA-3′ sequence 37 nucleotides downstream, therefore we
tested Xrn1 resistance of an RNA that ended immediately after
the 5′-GUCA-3′ (Fig. 5c). The wild-type version of this RNA was
able to block Xrn1, indicating that although the 5′-GUCA-3′
appears to be located within a downstream stem–loop structure,
this downstream stem–loop is not necessary for Xrn1 resistance.
To directly test the functional importance of the putative
pseudoknot, we individually mutated two of the four bases in the
apical loop or downstream pairing region and tested for
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Fig. 3 Characterization of Xrn1-resistant structures in the 3′-UTR of CFAV. a Above: Northern blot analysis of total RNA from CFAV-infected C6/36 cells,
using a probe to the viral 3′-UTR. Below: reverse transcription mapping of the 5′-end of the CFAV sfRNA using RNA from infected cells. M=mock infected,
I= infected. b In vitro Xrn1 resistance assay using the full 3′-UTR of CFAV. RppH= RNA 5′ Pyrophosphohydrolase (RppH). c Reverse transcription mapping
the Xrn1 halt site with RNA from b. d Left: Schematic of a typical MBFV xrRNA with the conserved sequence, secondary, and tertiary structures indicated.
Center: secondary structure model of CFAV xrRNA1. Predicted tertiary interactions analogous to those in the MBFV are shown and the Xrn1 halt site is
indicated. Right: Secondary structure model of CFAV xrRNA2. Predicted tertiary interactions are shown. The location of secondary structure elements is
shown in gray boxes. e Comparison of known tertiary interactions in the MBFV xrRNAs with predicted analogous interactions in CFAV xrRNAs, with
sequence variation. f Testing of predicted interactions in the CFAV xrRNA1 that differ compared to the MBFVs. g Sequence alignments of multiple ISFVs.
Absolutely conserved nucleotides are in yellow. Colored boxes and lines denote the tertiary interactions shown in d, with colors to match. The location of
secondary structure elements shown in d are indicated below. Accession numbers for sequences used in b–d and f: CFAV, NC_001564; Aedes flavivirus
(AeFV), NC_012932; Kamiti River virus (KRV), NC_005064. Gels are representative of greater than three independent experiments
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the ability to block Xrn1, but the presence of both mutants in the
same RNA (compensatory) restored activity (Fig. 5d). We then
made RNAs in which the 3′-end was truncated 10 nucleotides at a
time to remove the 5′-GUCA-3′ sequence and shorten the 3′-end
(Fig. 5d; mutants −10, −20, −30); none could block Xrn1. Owing
to the lack of an infectious cDNA we verified the importance of
the long-range interaction by transfecting BHK-21J cells with a
Sindbis virus replicon RNA containing either the 3′-UTR of
MODV or MMLV; analysis of the resultant RNAs by Northern
blot revealed the production of sfRNAs from replicons containing
the WT 3′-UTRs, but a loss of sfRNA production when the long-
range interaction was eliminated (Supplementary Fig. 3). Finally,
we made internal deletions to the single-stranded RNA located
upstream of the 5′-GUCA-3′ sequence; these mutants retained the
potential for base pairing but changed the sequential distance
between the putative paired nucleotides (Fig. 5e; mutants Δ15,
Δ10, Δ5). When challenged with pure Xrn1 in vitro, none of
these mutants blocked the exoribonuclease. These results indicate
that the putative long-range base pairing sequence is important
for function and that the functional 3′-end of the xrRNA lies
immediately after this sequence. Furthermore, the intervening
RNA between the putative pairing sequences, whereas predicted
to be single-stranded, is also important, although it is not clear
whether this is to maintain a certain length or if there are specific
sequence requirements.
Using information from the secondary structures of the TBEV,
MODV, and MMLV RNAs, we aligned the sequences of likely
xrRNAs from additional TBFV and NKVFVs (Supplementary
Fig. 4 and 5). Although there is substantial sequence variation, all
show patterns that are consistent with the ability of the RNA
within each group to form similar secondary structures and long-
range interactions. Interestingly, the intervening RNA between
the putative long-range sequences contains conserved sequences,
suggesting it has some important role despite it appearing to be
single-stranded. Overall, these results suggest that a common
structure enables Xrn1 resistance (and thus sfRNA production) in
these 3′-UTRs, but that the secondary structure differs from those
found in the MBFVs and ISFVs (Fig. 6a).
Discussion
The RNA genomes of MBFVs harbor Xrn1-resistant structures in
their 3′-UTRs, which block the progression of the exoribonu-
clease to produce disease-related noncoding RNAs6,11. This
programmed resistance to Xrn1 depends on a specific folded
three-dimensional RNA structure that is highly conserved across
the MBFVs22,23,25,27. In this work, we interrogated the
mechanism for this RNA structure-driven process and we
identified and characterized xrRNAs in other flaviviruses. These
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Fig. 4 Examination of sfRNAs and direct Xrn1 resistance in TBFVs and some NKVFVs. a Northern blot analysis of total RNA from BHK-21J cells infected
with various viruses, using a probe of the viral 3′-UTR. M=mock infected. b Reverse transcription mapping of the 5′-end of the sfRNAs from a. M=mock
infected, I= infected. c In vitro Xrn1 resistance assay with the 3′-UTR of TBEV. RppH= RNA 5′ Pyrophosphohydrolase (RppH). 1 and 2 denote two Xrn1-
resistant products. d Xrn1 resistance assay with the 3′-UTRs of MMLV and MODV. e Reverse transcription mapping of the Xrn1 halt sites in the 3′-UTR of
TBEV. f Reverse transcription mapping of the Xrn1 halt sites in the 3′-UTR of MMLV and MODV. Accession numbers for RNA sequences used in c–f: TBEV,
NC_001672; MMLV, MC_004119; MODV, NC_003635. Gels are representative of greater than three independent experiments
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Fig. 6 Correlation of classes of flavivirus xrRNA with viral phylogeny. a Cartoon representation of the basic secondary structure of two types of flavivirus
xrRNAs. The secondary structural elements in each are labeled with a proposed nomenclature. Key differences between the two are described. Green lines
and arrows indicate long-range base pairing, red arrows indicate the halt point for Xrn1. b The phylogenetic tree of the Flaviviridae is an adaptation from
Vlachakis et al.52. Shaded boxes indicate the clades of viruses that have similar classes of xrRNA, based on our structural and functional analysis. There are
two clades of NKVFVs; one group has ‘Class 1’ xrRNAs that match the mosquito-borne viruses, and the other has ‘Class 2’ xrRNAs that align with the tick-
borne viruses. Abbreviations not used in main text: ZIKV: Zika virus; POWV: Powassan virus; TABV: Tamana bat virus
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Fig. 5 Characterization of NKVFV and TBFV xrRNAs. Secondary structures of relevant parts of the 3′-UTRs of a TBEV, bMMLV, and cMODV. The mapped
Xrn1 halt site is indicated with black arrows. Nucleotides are shaded to indicate their normalized SHAPE reactivity. d Xrn1 resistance assay using wild-type,
mutant, and truncated MODV xrRNA. The diagram at the top shows the mutations made. e Same as d, with deletions to the single-stranded RNA upstream
of the 3′ part of the putative long-range interaction. Accession numbers for RNA sequences used: TBEV, NC_001672; MMLV, MC_004119; MODV,
NC_003635. Gels are representative of greater than three independent experiments
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viruses and hosts, the evolution of xrRNAs, the possibilities of
analogous RNAs in other contexts, and the use of xrRNAs in
nanotechnology or synthetic biology.
Previously solved structures allowed many new questions to be
proposed regarding the mechanism of xrRNA resistance, which
until now were untested. A central mystery was whether xrRNAs
were evolved to interact with and block Xrn1 exclusively, which
would suggest that specific interactions are needed between the
xrRNA and the enzyme to elicit Xrn1-specific effects. In contrast,
if xrRNAs could halt diverse 5′–3′ exoribonucleases, this would
reveal that the structure is a general mechanical block. Consistent
with the latter idea, we show that a representative MBFV xrRNA
is also capable of halting RNase J1 and Dxo1, directly demon-
strating the general nature of the ability to halt diverse exoribo-
nucleases and arguing against the importance of specific contacts
between the xrRNA and amino acids on the enzyme’s surface.
The fact that RNase J1 and Dxo1 are enzymes that xrRNAs never
naturally encounter, and that xrRNAs can block their
progression, are strong evidence in support of this. Also, the fact
that these enzymes stop at different locations relative to the
xrRNA structure is consistent with the idea that the structure
braces against the surface to stop exoribonuclease progression,
and this difference is a measure of the distance between the
surface and the active site in the enzyme’s interior23,31. Last,
although specific contacts between the xrRNA and the enzyme
surface are not critical, our data suggest that the overall shape of
the surface and the type of helicase activity may affect xrRNA
efficiency.
Combined with previous data, the mechanism that emerges is
one in which xrRNAs resist progression of exoribonucleases using
a specific three-dimensional RNA fold that braces against the
surface of the enzyme and creates a general mechanical block to
continued enzyme movement. Several existing pieces of evidence
fit this mechanistic model. First, although the MBFV xrRNAs
block Xrn1 approaching from the 5′ side, the viral RNA-
dependent RNA polymerase can pass through from the 3′ side, as
can the reverse transcriptase used in our experiments. Although
the nature of these enzymes’ helicase activity may differ from
Xrn1’s, this observation is consistent with resistance owing to an
encounter with the 5′ side of the structure. Also, while the global
structural stability of the xrRNA may play a role in resistance,
Xrn1 passes through many very stable structured RNAs, sug-
gesting thermodynamic stability is not the sole source of resis-
tance38,39. Finally, the three-dimensional fold of the MBFV
xrRNAs contains a unique ring-like structure through which the
5′-end passes, a feature not previously seen in other RNA
structures23,27. Modeling shows that this ring contacts the
enzyme’s surface and encircles the entrance to the active site
while emerging single-stranded RNA extends into the active
site23,27. It is important to differentiate this ‘mechanical block’
model from one in which the overall thermodynamic stability of
the fold (predicted or measured) is the primary determinant of
resistance; rather than thermodynamic stability, resistance is
conferred by a specific RNA topology that the enzyme encounters
as it approaches from the 5′ side, and this structure presents a
specific barrier to progression.
The mechanism supported by the data has several implications
for the function of these xrRNAs in flavivirus infection. The
ability of the MBFV xrRNAs to resist diverse exoribonucleases
may assist them in operating in a wide range of hosts and vectors.
In other words, sequence differences in Xrn1 from different
species are unlikely to result in an enzyme that is able to degrade
through an xrRNA. Although viral tropism is dependent on many
factors, at least the xrRNA is likely to be functional in a very wide
range of species17,18. Likewise, versions of Xrn1 capable of
overcoming xrRNAs are unlikely to arise through a specific
mutation within a species, eliminating one host-centered
mechanism of evolving resistance to the virus. The ability to
block diverse exoribonucleases also confers the potential to use
processive 5′–3′ exoribonucleases other than Xrn1 to produce
sfRNAs. Indeed, Xrn1 knockdown experiments in Zika virus
suggested the presence of redundancy in the 5′–3′ decay
machinery that could be exploited by xrRNAs that block diverse
exoribonucleases27.
The ability to halt Xrn1 and potentially other cellular exori-
bonucleases is shared across the flavivirus genus, although the
RNA structural determinants of this function have diverged.
Specifically, comparing the structural characteristics of the Xrn1-
resistant elements from some members of the NKVFVs and the
TBFVs with those from the MBFVs reveals obvious differences.
Although the experimentally-supported secondary structure
models of these diverse xrRNAs all contain three-way helical
junctions, they are only superficially similar when compared with
known RNA three-way junctions37. In addition, the distance (in
terms of sequence length) between the sequences involved in a
putative long-range base pairing interaction is longer than is
typical for the MBFVs25. Likewise, the halt point for the exori-
bonuclease in the tested NKVFV and TBFV xrRNAs lies within a
helical element and only 5–6 nucleotides upstream of the junc-
tion. This is potentially significant because as the enzyme
approaches, it will unwind these helical elements, with the effect
of further increasing the amount of single-stranded RNA between
the structure and the long-range base pairing. Furthermore, at the
moment the enzyme halts, the 5–6 nucleotides between the
junction and the halt point will be single-stranded and inside the
enzyme, suggesting a different RNA structure-based mechanism
of halting Xrn1. Although it is possible that these divergent
secondary structures and sequences may possess three-
dimensional folds or topologies similar to those from the
MBFV, it is premature to make this prediction; it is just as pos-
sible that they use a different tertiary structure and strategy to
block Xrn1. These observations suggest there are at least two
secondary structural classes of xrRNAs within the flavivirus
genus: the well-characterized class typified by the MBFVs and
ISFVs (Class 1) and the class found in the TBFV and some of the
NKVFVs (Class 2) (Fig. 6a).
It is also worth considering that outside the flavivirus genus
but within the Flaviviridae family, the hepatitis C virus
(a hepacivirus) and bovine viral diarrhea virus (a pestivirus) have
been shown to block Xrn1 progression past a point proximal to
the 5′-end of the viral genomic RNA, resulting in dysregulation of
host RNA decay pathways40. However, Xrn1 resistance does not
appear to be as robust as in the MBFVs and serves a
somewhat different purpose in that it does not result in
accumulation of a noncoding RNA that alters multiple host
pathways during infection. Also, there is no evidence of a three-
dimensional RNA structure that is similar to the xrRNAs found
in the MBFV 3′-UTRs. Nonetheless, the presence of the ability to
resist Xrn1 by these members of the Flaviviridae family outside
the flavivirus genus show how useful this ability may be for
viruses, inviting speculation that this function may exist
throughout the viral RNA world. Indeed, exoribonuclease-
resistant RNA sequences have been reported in some plant-
infecting viruses that show no sequence similarity to the flavivirus
xrRNAs41.
It is informative to examine the diverse RNA structure-based
ways to halt Xrn1 in light of the phylogenetic relationship of the
Flaviviridae and their use of different arthropod vectors (Fig. 6b).
In the viruses that are known to infect mosquitos (two groups of
MBFVs and ISFVs), there is clear evidence for the existence of
xrRNAs that follow a specific secondary structure pattern and
adopt a similar three-dimensional fold. For the purposes of
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discussion here, we refer to these as “Class 1” flavivirus xrRNAs.
At least some likely NKVFVs use xrRNAs of this type, for
example YOKV25. In contrast, the viruses that are known to
infect ticks are using “Class 2” flavivirus xrRNAs with different
secondary (and perhaps tertiary) structural features. Consistent
with this, MODV and MMLV are members of the NKVFVs that
are overall more closely related to TBFVs, and their xrRNAs
match that class. Hence, the point of divergence of Class 1 from
Class 2 xrRNAs appears to be near the point where MBFVs and
TBFVs phylogenetically diverge and where the diverse NKVFVs
lay. We hesitate to make strong conclusions based on these
observations; nonetheless it will be interesting to see if future
identification of any arthropod vectors for these various NKVFVs
shows that the class of xrRNAs correlates with the vector; that is,
if Class 1 xrRNAs are exclusive to mosquitoes and Class 2
xrRNAs are exclusive to ticks.
Within the areas of RNA-based nanotechnology, synthetic
biology, and RNA-based therapies, viral RNAs such as xrRNAs
can provide elegant building blocks for diverse applications. One
can imagine a wide range of applications where it would be
advantageous to control the degradation of specific RNA species.
Given that the flavivirus xrRNAs are active against a range of
exoribonucleases from different species, they might also be uti-
lized as tools within a range of organisms to protect specific
RNAs from 5′–3′ decay. The widespread presence of xrRNAs in
the flaviviruses, the diversity of sequences and structures
capable of mechanically blocking different exoribonucleases,
and the apparent usefulness of this strategy for viral infection
suggests that RNA structures capable of interfering with exori-
bonuclease activity may be more widespread than is currently
appreciated.
Methods
Protein purification. The RppH and Xrn1 enzymes were expressed and purified as
described22. The RNase J1 expression vector was a kind gift of Ciaran Condon, and
the Dxo1 expression vector was a kind gift of Liang Tong. RNase J1 was expressed
in BL21 (DE3) cells in LB containing kanamycin and chloramphenicol at 30 °C.
Expression was induced with 0.1 mM IPTG at OD600 = 0.6 and protein was
expressed at 30 °C for 3 h. The cells were harvested by centrifugation at 5488×g for
10 minutes and the cell pellets were stored at −80 °C until further use. Dxo1 was
expressed in Rosetta (DE3) cells in LB with kanamycin. The cells were grown at
37 °C to OD600 = 0.6–0.9. Expression was induced with 0.25 mM IPTG, the tem-
perature was lowered to 16 °C and culture continued overnight before harvesting
and storing similar to RNase J1 (above). Cell pellets were lysed by sonication for 2
minutes processing time and centrifuged at 31,000×g for 30 minutes to clear the
lysate. The protein was purified using Ni-NTA resin (Thermo) in a gravity flow
column followed by size exclusion chromatography with either a Superdex 75 or
Superdex 200 column. The final product was stored in buffer containing 20 mM
Tris pH 7.3, 300 mM NaCl, 1 mM DTT or 2 mM BME, and 10% glycerol (1 mM
EDTA was added to the RNase J1 sample) at −80 °C. The purity was assessed by
SDS-PAGE and Coomassie staining.
RNA synthesis. Plasmids encoding the RNA sequences of interest under control of
a T7 promoter were generated using standard molecular biology techniques. In
brief, gene fragments (gBlocks) synthesized by Integrated DNA Technologies (IDT)
were ligated into pUC19 vector (NEB) between the BamHI and EcoRI sites.
Resultant plasmids were amplified in Escherichia coli (DH5α) and their sequences
verified. To generate DNA template for transcription reactions, the desired region
of the plasmid was amplified by PCR, then used in 5 mL in vitro transcription
reactions and purified as previously described22.
Degradation resistance assay of the 3′-UTRs. The exoribonuclease resistance
assays were carried out by first folding 1–2 µg of 3′-UTR RNA and 1 µg of the 24-
mer control RNA in a buffer composed of 50 mM Tris, pH 7.9, 100 mM NaCl, 10
mM MgCl2, 1 mM DTT. This solution was incubated at 85 °C for 3 min, followed
by 20 °C for 5 min, then held at 4 °C. Then, 0.8 µg of His-Xrn1 and 0.08 µg of His-
BdRppH were added and the mixture was incubated at 37 °C for 2 h. The resulting
RNA products were analyzed by denaturing PAGE22.
Mapping halt sites of 3′-UTRs. Exoribonuclease halt sites were mapped by gel
purifying His-Xrn1 digested 3′-UTR flavivirus RNA using the same protocol as
mentioned above but at a larger scale (20 µg RNA total). Then RT-PCR was
performed using unique 5′-end-labeled primers for each flavivirus and GoScript
Reverse Transcriptase (Promega)22. The RT products were resolved on a 12%
denaturing polyacrylamide sequencing gel. The gels were visualized by phos-
phorimaging using a Typhoon 9400 Imager (Molecular Dynamics) and visualized
with ImageQuant software.
Chemical probing and computational analysis. We utilized the one-dimensional
(1D) chemical probing method described by Cordero et al. to conduct our SHAPE
experiments and analysis42. In brief, RNAs were transcribed as described above,
and purified using Agencourt AMPure XP magnetic beads. To anneal the RNA, it
was heated to 90 °C for 2 minutes, transferred to ice for 2 minutes, and then placed
at room temperature. RNA was modified via exposure to 24 mg/mL NMIA for 30
minutes before halting the reaction with an acid quench solution (1 volume 5M
NaCl, 1 volume 2M HCl, and 1.5 volumes 3M sodium acetate pH 5.2)42. Modified
RNAs were then reverse transcribed at 42 °C for 45 minutes with a universal
fluorescently labeled primer (IDT) (/5–6FAM/ AAAAAAAAAAAAAAAAAAAA
GTTGTTGTTGTTGTTTCTTT). Labeled cDNA products were eluted in HiDi
formamide and Gene Scan ROX 350 (Thermo) for capillary electrophoresis
analysis on an Applied Biosystems 3500 XL Genetic Analyzer42. All reactions were
performed in triplicate, as were “no modification” control reactions and
ddNTP ladders. Analysis of capillary electrophoresis data was performed using
the HiTRACE MATLAB toolkit (MathWorks) and 1D analysis pipeline
developed by the Das and Yoon labs43–46. For further information, the website and
tutorial for these programs and protocols can be found at: https://hitrace.github.io/
HiTRACE/.
Cell culture and viral infections. The origin and culture conditions of the
BHK-21J (obtained from the Laboratory of Professor C.M. Rice, at the time at
Department of Molecular Microbiology, Washington University School of
Medicine, St. Louis, Missouri) and C6/36 (ATCC CRL-1660) cells have been
described47–49. Infections were performed as previously described48. Total RNA
was isolated with Trizol (Invitrogen) at 30 h.p.i. from BHK-21J cells infected with
MODV, APOIV, MMLV, or RBV (viruses were obtained from Professor J. Neyts at
The Laboratory of Virology in the Rega Institute for Medical Research, Leuven,
Belgium), or at 36 h.p.i. from CFAV-infected C6/36 cells (obtained from Professor
X. Delamballerie at the UVE, Université Aix-Marseille II, Faculté de Médecine,
Marseille, France).
Replicon construction and transfection. Viral RNA isolated from infected cells
(see above) was dissolved in 30 ml H2O and 5 μg was used for RT-PCR to amplify
the Xrn1 stalling site-containing region of either MODV (nts. 10247–10343) or
MMLV (nts. 10265–10367). Primers for these reactions can be found in Supple-
mentary Table 1. The amplified MODV and MMLV cDNA fragments were cloned
into Mlu I—Sph I-digested pSinrep5 and used for in vitro RNA transcription as
described26,50 (Supplementary Table 2).
RNA transfection and northern blot analysis. BHK-21J cells were transfected
with 5 μg of in vitro transcribed Sinrep5 recombinant RNAs as described48,50.
Approximately 1.5 × 106 transfected BHK-21J cells were seeded in a 35 mm plate.
Total RNA was isolated from the transfected cells at 8 h post-electroporation using
Trizol (Invitrogen). For Northern blotting, 7.5–10 μg of total RNA isolated from
either infected or electroporated cells was denatured using formaldehyde and
separated on a formaldehyde-containing 1.5% agarose gel and blotted to Hybond-
N+ (GE Healthcare)51. The blots were hybridized using 32P-labeled oligonucleo-
tides as probes (Supplementary Table 1).
Sequence Alignments. Sequences were aligned using CLUSTALW though the
online server. Accession numbers of sequences are contained in the appropriate
figure legends.
Data availability. All data are available from the authors upon request.
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